US 2010/0144800 A1Published application

Extended release tablet formulation of niacin

AssigneeRanbaxy Laboratories Limited

InventorsChayapathy Issa, Praveen Raheja, Sachin Arora, Rajesh Gandhi, Rajeev Shanker Mathur

Life of this patent

Estimating the term…

Abstract

The present invention relates to an extended release tablet formulation comprising niacin and a release retarding agent selected from hydroxypropyl cellulose, polyethylene oxide or mixtures thereof.

Claims9

Dependent claims

An extended release tablet formulation comprising niacin, a release retarding agent selected from hydroxypropyl cellulose, polyethylene oxide or mixtures thereof, and one or more pharmaceutically acceptable excipients.

Dependencies are inferred from the claim text.

Facts

Application: 12/482,290Filed 10 Jun 2009
Priority: IN 1386/DEL/200811 Jun 2008
Published: 10 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/455
Non condensed pyridines; Hydrogenated derivatives thereof: nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
A61K 9/2027
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 9/2077
Characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets;…: tablets…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results